PUMA BIOTECHNOLOGY, INC. (PBYI) Free cash flow 2016–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$41.7MFY2025 · since FY2016: -$146.0M → $41.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $41.7M | +7.4% |
| FY2024 | $38.9M | +44.6% |
| FY2023 | $26.9M | +269.8% |
| FY2022 | -$15.8M | -176.6% |
| FY2021 | $20.6M | +2740.4% |
| FY2020 | $727,000 | -96.7% |
| FY2019 | $22.1M | +189.9% |
| FY2018 | -$24.5M | +85.8% |
| FY2017 | -$172.9M | -18.4% |
| FY2016 | -$146.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice